1.67
2.45%
0.04
시간 외 거래:
1.62
-0.05
-2.99%
전일 마감가:
$1.63
열려 있는:
$1.62
하루 거래량:
82,335
Relative Volume:
1.28
시가총액:
$7.55M
수익:
$98,000
순이익/손실:
$-86.59M
주가수익비율:
-0.3064
EPS:
-5.45
순현금흐름:
$-48.49M
1주 성능:
-21.23%
1개월 성능:
-62.64%
6개월 성능:
-75.79%
1년 성능:
-87.81%
Biora Therapeutics Inc Stock (BIOR) Company Profile
명칭
Biora Therapeutics Inc
전화
855-293-2639
주소
4330 LA JOLLA VILLAGE DRIVE, SAN DIEGO
BIOR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
BIOR | 1.67 | 7.55M | 98,000 | -86.59M | -48.49M | -5.45 |
VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Biora Therapeutics Inc 주식(BIOR)의 최신 뉴스
Biora Therapeutics Reports Q3 2024 Results and Updates - TipRanks
Biora Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Highbridge Capital Management's Strategic Acquisition of Biora T - GuruFocus.com
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewswire
Biora Therapeutics Advances BioJet Device, Cuts Monthly Expenses 40% Amid Q3 Loss | BIOR Stock News - StockTitan
Biora Therapeutics Inc (BIOR) Q3 2024 Earnings Report Preview: W - GuruFocus.com
Biora Therapeutics Inc (BIOR) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
S&P 500 price target raised at Oppenheimer after 'decisive' election results - Investing.com
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewswire
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
SEC Form 424B5 filed by Biora Therapeutics Inc. - Quantisnow
SEC Form 424B3 filed by Biora Therapeutics Inc. - Quantisnow
Biora Therapeutics announces $3 million stock and warrant sale - Investing.com India
Biora Therapeutics advances oral drug delivery tech By Investing.com - Investing.com Nigeria
Biora Therapeutics advances oral drug delivery tech - Investing.com India
Biora Therapeutics Shares Progress on Smaller BioJet™ - GlobeNewswire
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting - StockTitan
Progenity Inc stock hits 52-week high of $5.2 amid market fluctuations - Investing.com
Biora Therapeutics Inc’s results are impressive - US Post News
Market Highlights: Biora Therapeutics Inc (BIOR) Ends on a Low Note at 0.55 - The Dwinnex
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting - The Manila Times
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the - GlobeNewswire
Biora Therapeutics enacts reverse stock split, adjusts shares By Investing.com - Investing.com Australia
Biora Therapeutics enacts reverse stock split, adjusts shares - Investing.com India
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium - The Manila Times
Biora Therapeutics Announces Award-Winning Abstract to be - GlobeNewswire
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024 - Yahoo Finance
Biora Therapeutics Inc’s Market Journey: Closing Weak at 0.59, Down -9.63 - The Dwinnex
Biora Therapeutics Inc Inc. (BIOR) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Biora Therapeutics secures additional $4 million financing - Investing.com India
Biora Therapeutics secures additional $4 million financing By Investing.com - Investing.com UK
Biora Therapeutics Achieves ISO 13485 Certification - GlobeNewswire
A History of Outperforming Analyst Forecasts and Beating the Odds: Biora Therapeutics Inc (BIOR) - SETE News
Biora Therapeutics Announces Positive Nasdaq Listing Decision - GlobeNewswire
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Biora Therapeutics secures new financial agreements - Investing.com India
BIOR: Second Quarter Results - Yahoo Finance
Biora Therapeutics, Inc. (NASDAQ:BIOR) Forecasted to Post Q3 2024 Earnings of ($0.42) Per Share - Defense World
BIOR’s Stock Woes: Down -20.37% in 6 Months, Down -20.37% in Just 5 Days - The InvestChronicle
Biora Therapeutics Second Quarter 2024 Earnings: EPS: US$0.18 (vs US$1.47 loss in 2Q 2023) - Yahoo Finance
Biora Therapeutics (NASDAQ:BIOR) Receives “Buy” Rating from HC Wainwright - Defense World
Biora Therapeutics Inc (BIOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):